EUVIMEDEUVIMED entdecken
Crossref

11-Year follow-up of percutaneous pulmonary valve implantation (PPVI) in central South Africa

Dhesan N Pillay, Stephen C Brown, Daniël G Buys

Cardiovascular Journal of Africa · 2025

DOI: 10.5830/cvja-2025-071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Journal of Africa, 2025. Verfasst von Dhesan N Pillay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universitas Academic Hospital, Bloemfontein, South Africa . Email: dhesan.n.pillay@gmail.com. Hauptthemen laut MEDLINE: Pulmonary Valve, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Pulmonary Valve Insufficiency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Excellent mid-term outcomes are well-established for percutaneous pulmonary valve implantation (PPVI) in treating right ventricular outflow tract (RVOT) dysfunction. Despite this success, long-term data assessing PPVI performance are limited, especially within middle- to low-income country contexts. OBJECTIVE: To report on the patient characteristics and long-term outcomes after PPVI. METHODS: This retrospective study describes outcomes for 31 PPVI patients treated from 2012 to 2023 at the paediatric cardiology department, Universitas Academic Hospital, Bloemfontein, South Africa. RESULTS: The predominant underlying diagnosis was tetralogy of Fallot (n = 20, 64.5%). The primary indications for PPVI were pulmonary insufficiency (PI) (n = 15, 48.4%), followed by mixed PI and right ventricular outflow tract (RVOT) stenosis (n = 10, 32.3%), and isolated pulmonary/RVOT stenosis (n = 6, 19.4%). Most implants (n = 22, 71%) were placed within homograft conduits. One early death occurred during the study period, yielding a procedural mortality rate of 3.2%. At 10 years, Kaplan-Meier estimated valve survival was 77%, freedom from stent fracture was 85.3%, and freedom from infective endocarditis (IE) was 81%. The annualised incidence of IE was 1.9%. CONCLUSIONS: These findings contribute long-term data on PPVI outcomes from a middle-income country setting. The results demonstrate favourable durability and performance, appearing comparable to surgical pulmonary valve replacement benchmarks. However, IE remains a significant long-term complication, underscoring the potential importance of implementing and adhering to stringent prophylactic protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary ValveHeart Valve Prosthesis ImplantationCardiac CatheterizationPulmonary Valve InsufficiencyPulmonary Valve StenosisHumansSouth AfricaRetrospective StudiesFemaleMaleTime FactorsChildChild, PreschoolHeart Valve ProsthesisRisk FactorsTreatment OutcomeVentricular Outflow Obstruction, RightInfantAdolescentRecovery of FunctionVentricular Function, Right

Stichwörter der Autor:innen

Edwards valveMelody valvePPVISouth Africapercutaneous pulmonary valve implantationvalve replacement

Autor:innen und Institutionen

  • Universitas Academic Hospital, Bloemfontein, South Africa . Email: dhesan.n.pillay@gmail.com.
  • Universitas Academic Hospital, Bloemfontein, South Africa.

Zitieren

APA

Pillay, D. N., Brown, S. C., & Buys, D. G. (2025). 11-Year follow-up of percutaneous pulmonary valve implantation (PPVI) in central South Africa. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2025-071

Vancouver

Pillay DN, Brown SC, Buys DG. 11-Year follow-up of percutaneous pulmonary valve implantation (PPVI) in central South Africa. Cardiovascular Journal of Africa. 2025. doi:10.5830/cvja-2025-071

BibTeX
@article{Pillay2025,
  author = {Pillay, Dhesan N and Brown, Stephen C and Buys, Daniël G},
  title = {11-Year follow-up of percutaneous pulmonary valve implantation (PPVI) in central South Africa},
  journal = {Cardiovascular Journal of Africa},
  year = {2025},
  doi = {10.5830/cvja-2025-071}
}
Kostenlos starten →